Axon Therapeutics, Inc. — Form D
Axon Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-25. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-08-25
- Form: D
- Accession: 0001943790-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 2
- Date of first sale: 2022-08-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-457035
Issuer
- Name: Axon Therapeutics, Inc.
- CIK: 0001943790
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3993 VIA CANGREJO, SAN DIEGO, CA, 92130
- Phone: 858-630-5241
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| David c Dodick | Director | San Diego, CA |
| Frank c Porreca | Director | San Diego, CA |
| Pierre Riviere | Director | San Diego, CA |
| Pierre Riviere | Executive Officer | San Diego, CA |
More